- Cell and molecular biology
- Biomarkers
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging and interventional therapeutics
- Systems biology, post-genomic analysis and emerging technologies
- Survivorship
Call for Submissions: 'Microbiome and Cancer' Collection
The Editors of BMC Cancer and BMC Microbiology are exited to announce the launch and invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin.
Open for submissions until 1st May 2021. Submit now!
Support and Guidance
Planning to submit a systematic review?
Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here.
Submitting a study protocol?
Find out more about the journal's criteria and scope for study protocols here.
BMC Series Focus Issue
© Maksim Kabakou
January: Data sharing
Research data are the foundations of reliable and reproducible science. This month, we would like to highlight different ways authors were able to publish and share their data by choosing the BMC series.
Articles
-
-
Risk factors of breast cancer among patients in a tertiary care hospitals in Afghanistan: a case control study
-
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
-
Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy
-
A review of new hormonal therapies for prostate cancer in black men: is there enough data?
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Atypical glandular cells in conventional cervical smears: Incidence and follow-up
-
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma
Featured video: Microparticles, breast cancer's secret weapon?
Your browser needs to have JavaScript enabled to view this video
Featured article: Are cancer patients better off if they participate in clinical trials?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Aims and scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
Journal Sections
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Blog
-
-
Highlights from the BMC Series – November
04 January 2021
-
The forgotten Covid-19 ‘survivors’
21 December 2020
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
Follow
2019 Journal Metrics
-
Citation Impact
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)Usage
4,151,734 downloads
Social Media Impact
3364 mentions
